according to a study published recently in Science Advances. “It’s pretty amazing,” says Paul Wender, a chemist at Stanford University. “In this new agent, we were seeing things that get up to 90 ...

One of the original HIV/AIDS patients in Sydney has died more than four decades after his diagnosis. Tributes have begun ...

HIV is spread by bodily fluids such as blood, breast milk, or semen. It gradually weakens the body's immune system and makes ...

Many small organizations that relied on USAID have shut down; even the largest ones have been severely weakened. One survey ...

The company has announced results from the first group of patients in its most recent phase 2a trial testing the potential HIV cure treatment codenamed ABX464. The study aimed at accessing the ...

The World Health Organization (WHO) has expressed deep concern over the impact of US funding cuts on critical global health ...

Trump’s pause in USAID spending has put major African HIV vaccine and prevention trials on hold, leaving the research world ...

By targeting infected cells in the brain, drug may clear virus ... Proof-of-Concept Study to Find Functional Cure for HIV July 24, 2024 — Researchers conducted a breakthrough proof-of-concept ...

With recent cuts to foreign aid, including programs like PEPFAR, thousands of Africans living with HIV face an uncertain ...

Preexposure prophylaxis, known as PrEP, reduces the risk of new HIV infections through sex by 99% and among injectable drug ...

A small French biotech is trumpeting results from a trial suggesting its developmental drug could be used as part of an HIV cure. The phase 2a trial of AbiVax’s ABX464 pill is small but confirms ...